Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.23.1
Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Feb. 05, 2023
Oct. 05, 2022
Aug. 08, 2022
Mar. 31, 2023
Jul. 11, 2022
Subsidiary or Equity Method Investee [Line Items]          
Issuance of warrants       $ 10,161  
Securities Purchase Agreement          
Subsidiary or Equity Method Investee [Line Items]          
Warrants outstanding (in shares) 2,000,000        
Warrant Agreement          
Subsidiary or Equity Method Investee [Line Items]          
Warrants outstanding (in shares)         61,200,000
Warrant Agreement | Securities Purchase Agreement          
Subsidiary or Equity Method Investee [Line Items]          
Warrants outstanding (in shares) 50,000,000        
Proceeds from Issuance of Warrants $ 49,400        
Purchase share price (in dollars per share) $ 1.05     $ 1.05  
Side Letter to the Wainwright Sales Agreement          
Subsidiary or Equity Method Investee [Line Items]          
Manager commissions, percent of gross proceeds   3.00%      
Sale of stock, percentage of additional fee   1.50%      
Registered Direct Offering & Placement Agency Agreement | Warrant Agreement          
Subsidiary or Equity Method Investee [Line Items]          
Corresponding increase in the total number of authorized share (in shares) 50,000,000        
Common stock          
Subsidiary or Equity Method Investee [Line Items]          
Issuance of warrants       $ 5  
Common stock | At The Market Offering Agreement          
Subsidiary or Equity Method Investee [Line Items]          
Sale of stock consideration     $ 200,000